Conventional second-line therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Conventional second-line therapy, covering 2024-12-30 to 2024-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment [NA]